![These highlights do not include all the information needed to use HETLIOZ safely and effectively. See full prescribing information for HETLIOZ. HETLIOZ® (tasimelteon) capsules, for oral use HETLIOZ LQ™ (tasimelteon) oral suspension These highlights do not include all the information needed to use HETLIOZ safely and effectively. See full prescribing information for HETLIOZ. HETLIOZ® (tasimelteon) capsules, for oral use HETLIOZ LQ™ (tasimelteon) oral suspension](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=hetlioz-13.jpg&id=680529)
These highlights do not include all the information needed to use HETLIOZ safely and effectively. See full prescribing information for HETLIOZ. HETLIOZ® (tasimelteon) capsules, for oral use HETLIOZ LQ™ (tasimelteon) oral suspension
![La FDA statunitense approva Hetlioz (tasimelteon): il primo farmaco per la sindrome di Smith-Maggie (SMS)! - Conoscenza - Hefei Home Sunshine Pharmaceutical Technology Co., Ltd La FDA statunitense approva Hetlioz (tasimelteon): il primo farmaco per la sindrome di Smith-Maggie (SMS)! - Conoscenza - Hefei Home Sunshine Pharmaceutical Technology Co., Ltd](http://it.hspchem.com/Content/uploads/2020524038/202012151451531c132e61011f4423abd0ff43a43b8631.gif)
La FDA statunitense approva Hetlioz (tasimelteon): il primo farmaco per la sindrome di Smith-Maggie (SMS)! - Conoscenza - Hefei Home Sunshine Pharmaceutical Technology Co., Ltd
![First drug approved to treat non-24 disorder affecting some blind people to be available this spring - cleveland.com First drug approved to treat non-24 disorder affecting some blind people to be available this spring - cleveland.com](https://advancelocal-adapter-image-uploads.s3.amazonaws.com/image.cleveland.com/home/cleve-media/width2048/img/health_impact/photo/hetlioz-non-24jpg-9ed83a485118bbff.jpg)
First drug approved to treat non-24 disorder affecting some blind people to be available this spring - cleveland.com
![HETLIOZ® (tasimelteon) is the first and only FDA-approved treatment for Non-24-Hour Sleep-Wake Disorder (Non-24) and nighttime sleep disturbances in Smith-Magenis Syndrome (SMS) HETLIOZ® (tasimelteon) is the first and only FDA-approved treatment for Non-24-Hour Sleep-Wake Disorder (Non-24) and nighttime sleep disturbances in Smith-Magenis Syndrome (SMS)](https://hetlioz.com/assets/header-logo-ed4a0eafea0a6d3ceec1cd9c4d717dea66814d23c9da61298b3f9181ff9546a6.jpg)